Liver and gastrointestinal immunologyMANNS, Michael P.Baillière's clinical gastroenterology. 1996, Vol 10, Num 3, issn 0950-3528, 167 p.Serial Issue

Immunopathogenesis of viral hepatitisREHERMANN, B.Baillière's clinical gastroenterology. 1996, Vol 10, Num 3, pp 483-500, issn 0950-3528Article

Primary sclerosing cholangitisMANNS, Michael P; BROOME, Ulrika.Baillière's best practice & research. Clinical gastroenterology. 2001, Vol 15, Num 4, issn 1521-6918, 141 p.Serial Issue

Autoimmune hepatitis, from mechanisms to therapyMANNS, Michael P; VOGEL, Arndt.Hepatology (Baltimore, Md.). 2006, Vol 43, Num 2, issn 0270-9139, S132-S144, SUP1Article

Medical and endoscopic treatment in primary sclerosing cholangitisMEIER, Peter N; MANNS, Michael P.Baillière's best practice & research. Clinical gastroenterology. 2001, Vol 15, Num 4, pp 657-666, issn 1521-6918Article

Republished paper: Managing HBV in patients with impaired immunityWURSTHORN, Karsten; WEDEMEYER, Heiner; MANNS, Michael P et al.Postgraduate medical journal. 2011, Vol 87, Num 1025, pp 223-238, issn 0032-5473, 16 p.Article

Autoimmune hepatitis: Clinical challengesMANNS, Michael P; STRASSBURG, Christian P.Gastroenterology (New York, NY. 1943). 2001, Vol 120, Num 6, pp 1502-1517, issn 0016-5085Article

Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinomaLECHEL, André; MANNS, Michael P; RUDOLPH, K. Lenhard et al.Journal of hepatology. 2004, Vol 41, Num 3, pp 491-497, issn 0168-8278, 7 p.Article

Immunopathology of primary biliary cirrhosisGALPERIN, C; GERSHWIN, M. E.Baillière's clinical gastroenterology. 1996, Vol 10, Num 3, pp 461-481, issn 0950-3528Article

Regulation of the mucosal epithelial barrierGÖKE, M; PODOLSKY, D. K.Baillière's clinical gastroenterology. 1996, Vol 10, Num 3, pp 393-405, issn 0950-3528Article

Managing HBV in patients with impaired immunityWURSTHORN, Karsten; WEDEMEYER, Heiner; MANNS, Michael P et al.Gut. 2010, Vol 59, Num 10, pp 1430-1445, issn 0017-5749, 16 p.Article

Immunotherapy of hepatocellular carcinomaGRETEN, Tim F; MANNS, Michael P; KORANGY, Firouzeh et al.Journal of hepatology. 2006, Vol 45, Num 6, pp 868-878, issn 0168-8278, 11 p.Article

Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance: Implications for novel antiviral strategiesTACKE, Frank; MANNS, Michael P; TRAUTWEIN, Christian et al.Current medicinal chemistry. 2004, Vol 11, Num 20, pp 2667-2677, issn 0929-8673, 11 p.Article

Adherence to combination therapy: influence on sustained virologic response and economic impactMANNS, Michael P.Gastroenterology clinics of North America. 2004, Vol 33, Num 1S, issn 0889-8553, xviii, S11-S24 [14 p.], SUPArticle

Animal models for primary sclerosing cholangitisVIERLING, John M.Baillière's best practice & research. Clinical gastroenterology. 2001, Vol 15, Num 4, pp 591-610, issn 1521-6918Article

Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitisVOGEL, Arndt; STRASSBURG, Christian P; MANNS, Michael P et al.Hepatology (Baltimore, Md.). 2002, Vol 35, Num 1, pp 126-131, issn 0270-9139Article

HCV's days are numbered: next-generation direct-acting antivirals and host-targeting agentsCALLE SERRANO, Beatriz; MANNS, Michael P.Antiviral therapy (London). 2012, Vol 17, Num 6, pp 1133-1146, issn 1359-6535, 14 p., bArticle

Liver transplantation for primary sclerosing cholangitis : timing, outcome, impact of inflammatory bowel disease and recurrence of diseaseWIESNER, Russell H.Baillière's best practice & research. Clinical gastroenterology. 2001, Vol 15, Num 4, pp 667-680, issn 1521-6918Article

Selenocysteine, soluble liver antigen/ liver-pancreas, and autoimmune hepatitisHERKEL, Johannes; MANNS, Michael P; LOHSE, Ansgar W et al.Hepatology (Baltimore, Md.). 2007, Vol 46, Num 1, pp 275-277, issn 0270-9139, 3 p.Article

Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetesJAECKEL, Elmar; VON BOEHMER, Harald; MANNS, Michael P et al.Diabetes (New York, NY). 2005, Vol 54, Num 2, pp 306-310, issn 0012-1797, 5 p.Article

Immunogenetics in liver diseaseDONALDSON, P. T.Baillière's clinical gastroenterology. 1996, Vol 10, Num 3, pp 533-549, issn 0950-3528Article

Mucosal allergy : role of mast cells and eosinophil granulocytes in the gutBISCHOFF, S. C.Baillière's clinical gastroenterology. 1996, Vol 10, Num 3, pp 443-459, issn 0950-3528Article

Antigen presentation in the intestinePANJA, A; MAYER, L.Baillière's clinical gastroenterology. 1996, Vol 10, Num 3, pp 407-425, issn 0950-3528Article

Differential glucocorticoid effects on repair mechanisms and NF-κB activity in the intestinal epitheliumGÖKE, Michael N; SCHNEIDER, Maren; BEIL, Winfried et al.Regulatory peptides. 2002, Vol 105, Num 3, pp 203-214, issn 0167-0115Article

Losing balance: cytokine signaling and cell death in the context of hepatocyte injury and hepatic failureLUEDDE, Tom; LIEDTKE, Christian; MANNS, Michael P et al.European cytokine network (Montrouge). 2002, Vol 13, Num 4, pp 377-383, issn 1148-5493, 7 p.Article